Abiopharma

🔍 Violette Shelia M. (Executive)

Company: Q32 Bio Inc. (QTTB)

Report Date: 2026-08-25

Detailed Transactions and Holdings:

• Sold 2,798 shares of Common Stock at $16.56 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: false | shares_owned_after: 127,771.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-25 | Code: H | nature_of_ownership: By Violette Holdings LLC | shares_owned_after: 36,277.00 | Footnotes: F2

Footnotes:

• F1: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.
• F2: Shares held by Violette Holdings LLC ("Violette Holdings"). The Reporting Person is a manager of Violette Holdings and disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that she is the beneficial owner of such shares for purposes of Section 16 of the Exchange Act or for any other purpose.